Synonyms: | |
Status: | Approved (2018) |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | L01XC25 |
UNII: | YI437801BE |
Primary Target | |
---|---|
CCR4 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Sezary Syndrome | 4 | D012751 | FDA |
Paraparesis, Tropical Spastic | 3 | D015493 | ClinicalTrials |
Lymphoma, T-Cell, Cutaneous | 3 | D016410 | ClinicalTrials |
Lymphoma, T-Cell, Peripheral | 2 | D016411 | ClinicalTrials |
Leukemia-Lymphoma, Adult T-Cell | 2 | D015459 | ClinicalTrials |
Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
Carcinoma | 1 | D002277 | ClinicalTrials |
Asthma | 1 | D001249 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1159266-37-1 |
ChEMBL | CHEMBL1743041 |
FDA SRS | YI437801BE |
Guide to Pharmacology | 6477 |